Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Thera break

<< Previous

Bullboard Posts

Next >>

Comment by scarlet1967on Feb 02, 2021 2:36pm

77 Views

Post# 32448796

RE:RE:Thera break

Well at least someone likes to have a whiner at times called pumper on this board.

scarlet1967 wrote:
I am back from that break why? Because when things heading south in a business one can’t afford to have breaks.

The company needs to get out there using all the tools to their disposal and sell the unheard/unconvinced story to thousands of hungry investors “stock at home” due to pandemic.

No time for radio silence not earlier, not now or in the future.